These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1437346)

  • 1. On nebulized intranasal glucocorticoids.
    König P
    Pediatr Pulmonol; 1992 Sep; 14(1):63. PubMed ID: 1437346
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observations of nebulized flunisolide in infants and young children with asthma and bronchopulmonary dysplasia.
    König P; Shatley M; Levine C; Mawhinney TP
    Pediatr Pulmonol; 1992 Aug; 13(4):209-14. PubMed ID: 1523030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal steroids: the way forward.
    Halliday HL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F158-9. PubMed ID: 21289014
    [No Abstract]   [Full Text] [Related]  

  • 4. Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia.
    Lauterbach R; Szymura-Oleksiak J
    Eur J Pediatr; 1999 Jul; 158(7):607. PubMed ID: 10412826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of bone mineral content measurement in preterm infants given corticosteroids for bronchopulmonary dysplasia].
    Tricoire J; Rolland M; Trémollières F; Ribot C
    Arch Pediatr; 1998 Jun; 5(6):697-9. PubMed ID: 9759223
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticosteroids for the treatment and prevention of bronchopulmonary dysplasia.
    Soll RF
    Neonatology; 2010; 98(2):109-10. PubMed ID: 20150749
    [No Abstract]   [Full Text] [Related]  

  • 7. Postnatal glucocorticoids in preterm neonates: use in French neonatal centres in 2006.
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F398. PubMed ID: 18723787
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
    Lauterbach R; Szymura-Oleksiak J; Pawlik D; Warchoł J; Lisowska-Miszczyk I; Rytlewski K
    J Matern Fetal Neonatal Med; 2006 Jul; 19(7):433-8. PubMed ID: 16923699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants.
    LaForce WR; Brudno DS
    J Pediatr; 1993 Feb; 122(2):285-8. PubMed ID: 8429447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.
    Avent ML; Gal P; Ransom JL
    Neonatal Netw; 1994 Apr; 13(3):63-9. PubMed ID: 7512192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled therapy in infants: why not nebulize glucocorticoids?
    Kamada AK; Szefler SJ
    Pediatr Pulmonol; 1992 Aug; 13(4):198-9. PubMed ID: 1523026
    [No Abstract]   [Full Text] [Related]  

  • 14. Nebulized furosemide in infants with bronchopulmonary dysplasia.
    Rastogi A; Luayon M; Ajayi OA; Pildes RS
    J Pediatr; 1994 Dec; 125(6 Pt 1):976-9. PubMed ID: 7996373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?
    Thébaud B; Lacaze-Masmonteil T; Watterberg K
    Pediatrics; 2001 Feb; 107(2):413-5. PubMed ID: 11158479
    [No Abstract]   [Full Text] [Related]  

  • 16. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
    Bassler D; van den Anker J
    Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey.
    Ogawa R; Mori R; Sako M; Kageyama M; Tamura M; Namba F
    Pediatr Int; 2015; 57(1):189-92. PubMed ID: 25711265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.
    Yates HL; Newell SJ
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F190-4. PubMed ID: 21115554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of bronchial asthma. Dosage forms for inhalational glucocorticoids].
    Steckel H
    Pharm Unserer Zeit; 2003; 32(4):314-22. PubMed ID: 12899069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.